SynthesisFrontiers in oncology2021

The Efficacy and Safety of Programmed Death-1 and Programmed Death Ligand 1 Inhibitors for the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Shukang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.